~ Podium presentations and showcase of device demonstrations UltraClear’s versatile platform of four different treatment modalities for skin regeneration – from facial rejuvenation and scar resurfacing to deep collagen reconstruction and signature pulsed histology
~ The abstract establishes the effectiveness of UltraClear on darker skins IV-VI
SMITHFIELD, RI, April 11, 2023 /PRNewswire/ — Acclaro Company, a medical technology company specializing in developing and delivering new solutions that meet the most demanding needs in medical aesthetics and surgery, announced today that four keynote addresses will be presented at the American Society for Laser Medicine and Surgery (ASLMS) meeting in Phoenix, AZon April 13-16, 2023. Presentations will present clinical findings from single-session skin resurfacing studies using the new UltraClear 2,910 nm erbium-doped fluorine fiber laser, as well as data demonstrating histological changes associated with UltraClear’s advanced pulse characteristics. In addition, the results of a study evaluating the safety and efficacy of the UltraClear cold fiber ablation laser for the treatment of photoaging in skin of color will be shared.
“We continue to grow professional acceptance and patient preference for our UltraClear cold fiber ablation laser treatments for resurfacing,” said Mr. Shlomo Asa, UltraClear inventor, and Acclaro President. “At ASLMS 2023, we are proud to present positive results from our UltraClear studies for multiple indications, notably fractional facial rejuvenation, scar repair, skin color and histological data in ex-vivo skin samples. The clinical data, combined with very high patient satisfaction, validate the clinical flexibility, predictability and comfort of UltraClear treatment, thereby offering physicians and their patients an unrivaled aesthetic experience.”
UltraClear is the first cool ablative MID IR fiber laser FDA-cleared to treat multiple layers of skin—from the stratum corneum to the epidermis to the middermis—to help reverse the signs of aging and improve a variety of other concerns skin conditions in all skin tones. minimal downtime and limited use of anesthetics. UltraClear is differentiated 3DIntelliPulse The technology automatically combines ablative and coagulation energy across multiple skin layers with flexibility and precision, allowing providers to create personalized solutions based on each patient’s needs and specific skin type for maximum rejuvenation while minimizing unwanted side effects.
“Since our launch last year at ASLMS 2022, we have built a huge body of evidence to support the value and return on investment of UltraClear’s laser solution to address both professional and consumer needs today and into the future. On behalf of all of us at Acclaro, I would like to thank our medical experts and advisors for their spectacular partnerships and achievements,” added Mr. Assa, who also serves as Acclaro’s Chief Technology Officer.
ASLMS Details of Presentations:
Title: “Cutting Edge” presented by Dr. Susan Kilmer
Date and time: Thursday, 4/13/23 in the 9:15-10:00 am
Conferences: Pre-Conference Plenary, Level 300, Hall C
Title: “Evolving/Emerging Technology” device demonstrations presented by Dr. Paul Friedman
Date and time: Friday, 14/4/23 in the 13:00-14:30
Conferences: Special Event, Level 300, Hall C
Title: “Single Treatment Facial Resurfacing With A Novel Ablative Fractional Fiber Laser 2,910 nm” presented by Dr. Taryn Murray
Date and time: Friday, 14/4/23 in the 15:45
Conferences: Abstracts, Cutaneous Applications, Room 222
Title: “Single Treatment Scar Resurfacing With A Novel Ablative Fractional Fiber Laser 2,910 nm” presented by Dr. Emily Guo
Date and time: Friday, 4/14/23 in the 4:20 p.m
Conferences: Abstracts, Cutaneous Applications, Room 222
Title: “Histological Evaluation of a New Fractionated 2,910 nm Fiber Laser in Ex-vivo Blepharoplasty Skin Specimens” presented by Drs. Eric Bernstein
Date and time: Saturday, 4/15/23 in the 4:35 pm
Conferences: Abstracts, Dermal Applications, Room 222
Title: “Low-flux single treatment with a new 2,910 Nm fractional fiber laser ablative for photoaging on skin of color
Date and time: Saturday, 4/15/23 in the 4:37 pm
Conferences: Abstracts, Cutaneous Applications, Room 222
Title: “UltraClear Learning Lab”
Location: Acclaro Exhibition Booth #602
About UltraClear
UltraClear™ is the world’s first four-mode cold fiber removal laser that delivers unmatched results, efficiency and safety to improve quality of life. Its advanced software offers a range of patient-friendly treatment options tailored to their needs, lifestyle and skin types. From mid-day 3DMIRACL rejuvenating maintenance to deep rejuvenation and collagen remodeling, UltraClear™ provides personalized treatments with an effective and comfortable patient experience. Local anesthesia is not required for a wide range of procedures.
For more informationvisit www.Ultraclearlaser.com
About Acclaro Corporation
Founded in 2018 by a team of world-renowned experts and leading physicians, Acclaro Corporation is a rapidly growing US-based medical device company committed to developing game-changing solutions to address today’s most challenging unmet needs in the global medical aesthetics, ophthalmology and surgical markets. With decades of pioneering known innovations in laser technology and medicine, aesthetic applications, dermatological research and more than 50 published patents combined, Acclaro Corporation was founded to pave the way for the next generation of advancements.
For more information, please visit www.AcclaroMD.com
CONTACT ME:
Nadine Tosk Communications
Nadine Tosk, 504.453.8344
[email protected]
Acclaro Corporation
Christine Zajac
508-404-4700 |[email protected]
SOURCE Acclaro Corporation
